LEVI vs NCLH

LEVI presents a compelling growth-at-a-reasonable-price (GARP) opportunity, anchored by a stable Piotroski F-Score of 4/9 and a current price ($22.30) that sits comfortably below its growth-based intrinsic value of $40.12. While the Graham Number suggests a lower defensive floor of $13.25, the company's exceptional ROE of 25.41% and strong earnings growth (32.6% YoY) justify a premium. Despite bearish insider sentiment and a weak technical trend, the fundamental trajectory is supported by consistent earnings beats and a P/E ratio significantly lower than the sector average.

NCLH presents a high-risk profile characterized by a stable but mediocre Piotroski F-Score of 4/9 and a severe liquidity crisis. While analysts maintain a 'buy' rating based on a low forward P/E of 7.36 and a PEG of 0.43, the current price of $18.18 trades at a significant premium to both the Graham Number ($10.02) and the Intrinsic Value ($6.44). The company's balance sheet is critically leveraged with a Debt/Equity ratio of 7.03 and a Current Ratio of 0.21, indicating extreme difficulty in meeting short-term obligations.